(Q67903635)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833953%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Treatment of estrogen-dependent gynecological disorders with the gonadotropin releasing hormone agonist buserelin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833953%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

5 December 2022

author name string

K. Biberoglu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833953

5 December 2022

R. Gursoy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833953

5 December 2022

A. Yildiz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833953

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1833953

5 December 2022

publication date

1 June 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833953%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

http://www.tandfonline.com/doi/pdf/10.3109/09513599109028434

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Gynecological Endocrinology

5 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833953%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833953%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833953%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

109-122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833953%20AND%20SRC:MED&resulttype=core&format=json

Clinical applications of LHRH and its analogues

19 September 2019

cites work

3

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study

5 December 2022

4

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin

5 December 2022

5

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

New therapy for endometriosis

5 December 2022

7

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

5 December 2022

8

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography

5 December 2022

9

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up

5 December 2022

10

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata

5 December 2022

11

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri

5 December 2022

12

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Revised American Fertility Society classification of endometriosis: 1985

5 December 2022

13

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Effects of danazol, gonadotropin-releasing hormone agonist, and estrogen/progestogen combination on experimental endometriosis in the ovariectomized rat

5 December 2022

14

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness

5 December 2022

15

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Gonadotropin-releasing hormone analogs in the treatment of endometriomas

5 December 2022

16

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis

5 December 2022

18

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.

5 December 2022

19

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol

5 December 2022

20

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

Effects of nafarelin on bone density

5 December 2022

21

1 reference

https://api.crossref.org/works/10.3109/09513599109028434

5 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833953%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference